Profound Medical Affirms FY2026 Sales Guidance of $25.000M vs $26.858M Est
Benzinga Newsdesk 2 months ago
NewsGuidance
Profound Medical (NASDAQ:PROF) affirms FY2026 sales outlook from $25.000 million to $25.000 million vs $26.858 million estimate.
Profound Medical (NASDAQ:PROF) affirms FY2026 sales outlook from $25.000 million to $25.000 million vs $26.858 million estimate.